FUME Decodes Hidden Metabolic Issues Your Doctor Misses

FUME, India's leading diagnostic-first root-cause metabolic decoding platform, is addressing a silent epidemic of hidden metabolic dysfunction — the kind that standard blood tests routinely miss. A growing number of working professionals in India are caught in a frustrating paradox: their doctors tell them their blood reports look normal, yet they continue to battle stubborn weight gain, persistent fatigue, erratic energy, irregular hormones, or worsening blood sugar.

Standard healthcare, built around a limited set of markers, frequently misses the biological dysfunction quietly developing beneath the surface. FUME (Fix Underlying Metabolic Errors), a Bengaluru-based preventive health transformation platform, was built specifically to address this gap. Operating since 2020, FUME has supported more than 15,000 individuals across India, the UAE, the US, the UK, and Australia through a root-cause, diagnostic-informed approach to metabolic well-being.

The platform's philosophy is captured in a simple phrase: Decode. Don't Diet.

The Problem With Standard Blood Tests

Most conventional health check-ups test for limited basic diagnostic markers — fasting sugar, total cholesterol, thyroid-stimulating hormone, haemoglobin, and a handful of others. These tests were designed to detect disease once it has already formed, not to identify the metabolic dysfunction quietly building in the years before a clinical diagnosis.

FUME refers to this gap as the '5-Marker Trap’ — where standard health checkups may measure 25–30 basic markers, but only a handful provide meaningful insight into early metabolic dysfunction. By the time standard tests flag an abnormality, the underlying biological imbalance may have been present for years — silently affecting energy, hormonal balance, weight regulation, and long-term health trajectory.

The platform's proprietary framework, the FUME Bio-Intelligence System™, takes a fundamentally different approach. Rather than waiting for markers to cross a clinical threshold, it maps 85+ metabolic indicators including Homocysteine, fasting insulin, ApoB, hs-CRP, triglyceride-to-HDL ratio, and Lipoprotein(a) — along with genetic predisposition insights across 200+ health conditions and gut microbiome analysis to understand what is happening in the body before symptoms progress into disease.

As FUME frames it: most health programmes read the dashboard. FUME opens the engine.

A Platform Built From Personal Experience

FUME was co-founded by Jagannath Das (Jagan), an IIT Kharagpur alumnus, a former corporate executive with a 17-year career spanning Samsung, Bosch, and Aptiv, and an ISSA-certified health professional, along with Dr. Uma Mittal, PhD in Nutrition, certified by the Institute for Integrative Nutrition (IIN, New York), Precision Nutrition, and NASM, with Advanced Certificate in Functional Medicine & Clinical Nutrition.

Both founders have spoken openly about the personal health challenges that shaped the company's direction. Jagan faced obesity, early metabolic risk, and declining energy in his late thirties — despite conventional check-ups showing broadly acceptable results. Dr. Uma Mittal dealt with her own hormonal and metabolic challenges, which conventional symptom management alone was insufficient to address.

Their decision to explore root-cause approaches — examining genetics, gut health, hormonal patterns, and metabolic individuality — led to meaningful improvements in their own health outcomes. Combined, they attribute a 36-kilogram reduction and significant metabolic improvements to the functional medicine and lifestyle-based protocols that now underpin FUME's programmes.

That experience became the foundation for what they wanted to build.

"I am not the brand. Uma is not the brand. FUME is the brand," Jagan has noted — reflecting the founders' deliberate intent to build FUME as a scalable health institution rather than a personality-led coaching practice.

At the heart of FUME’s methodology is the FUME Bio-Intelligence System™ — a comprehensive diagnostic framework built to understand how different biological systems interact with one another, rather than evaluating health through isolated symptoms or single blood markers.

Depending on an individual’s metabolic profile, lifestyle patterns, and health objectives, the assessment process may involve genetic testing across 200+ health conditions, gut microbiome analysis, deep metabolic screening, hormonal analysis, 85+ advanced metabolic blood markers such as fasting insulin, Homocysteine, ApoB, hs-CRP, triglyceride-to-HDL ratio, and Lipoprotein(a), body composition studies, lifestyle stress mapping, and advanced biological insights related to inflammation, recovery, and long-term metabolic resilience.

Unlike conventional approaches that begin with generic recommendations, FUME begins with measurement — using multi-layer diagnostics to understand what is actually happening inside the body.

The platform’s philosophy is simple: meaningful health transformation begins when you understand how your body actually functions beneath the surface.

The result is a data-driven, personalised intervention protocol based on the individual's biological profile, rather than a generic plan applied uniformly to all.

Addressing India's Silent Metabolic Crisis

India carries one of the world's highest burdens of metabolic disease. An estimated 77 million Indians live with diabetes, with a similar number in a pre-diabetic state. Thyroid disorders affect an estimated 42 million people. PCOS is increasingly common among women of reproductive age. And a substantial proportion of those who appear metabolically healthy by standard measures — what researchers call the TOFI phenomenon, or Thin Outside, Fat Inside — carry dangerous levels of visceral fat and underlying metabolic dysfunction without knowing it.

FUME's programmes are designed to support individuals navigating these conditions by addressing the lifestyle contributors to metabolic dysfunction — not by positioning itself as a substitute for medical care, but as a complementary, preventive layer that sits upstream of disease progression.

The platform focuses on supporting improved outcomes for individuals dealing with:

• Insulin resistance and Type 2 diabetes-related metabolic patterns
• Thyroid dysfunction, Hashimoto's and subclinical hormonal imbalances
• PCOS and related hormonal disruption in women
• Stubborn weight gain despite diet and exercise efforts
• Chronic fatigue and adrenal-related stress patterns
• Gut inflammation and microbiome imbalance
• Metabolic factors associated with fertility challenges

FUME’s focus is preventive, lifestyle-driven, and education-based — supporting individuals in understanding and improving the root contributors to their metabolic well-being.

Scale, Outcomes, and Growing Reach

Since its formal launch in 2020, FUME reports having worked with more than 15,000 clients across more than 200 cities. The platform operates through a combination of its FUME FIT App, available on iOS and Android, and a team of dedicated health coaches providing daily 1:1 accountability support.

Programmes typically run from six months to one year and are designed as high-touch, personalised engagements — positioning FUME at the premium end of India's emerging preventive health market.

Beyond India, FUME is increasingly serving the NRI professional community — individuals in the US, UK, UAE, and Australia who seek metabolic health guidance grounded in Indian dietary and biological context.

A New Category in Indian Health

FUME's founders describe their longer-term ambition as more than building a business. They see the platform as part of a broader effort to define and legitimise a new category in Indian health: diagnostic-first, preventive metabolic care. FUME refers to this approach as 'metabolic decoding’ — using genetic, gut, and metabolic data to understand root causes before designing interventions.

Most Indians encounter preventive health only in the form of an annual full-body check-up — a snapshot that rarely reveals the underlying trajectory of metabolic function. FUME's proposition is that meaningful intervention is possible before chronic disease manifests, provided the right diagnostic picture is available and the right lifestyle changes are implemented with consistency and clinical support.

The platform's core metaphor captures this simply: Fix the engine, not the dashboard.

For the millions of working professionals, women navigating hormonal health, and individuals whose reports look normal but who feel far from well — FUME argues that better answers are available. They just require a different set of questions.

FUME (FUME Shredding Hub Private Limited) is a Bengaluru-based preventive root-cause metabolic health transformation platform founded in 2020 by Jagan and Dr. Uma Mittal. The platform supports individuals through personalised nutrition guidance, diagnostic-informed lifestyle protocols, and 1:1 accountability coaching underpinned by the proprietary FUME Bio-Intelligence System™. FUME has served more than 15,000 clients across India, the UAE, the US, the UK, and Australia. The FUME FIT App is available on iOS and Android.